While electrode shorting has been shown to be a safe and efficacious technique for minimizing DC at low stimulus rates (and therefore relatively long shorting periods), at higher rates (>500 pulses per second; pps) there is evidence of increased DC levels, particularly associated with high stimulus intensities
The purpose of the present study was to examine DC levels in vivo using high stimulus rates at stimulus intensities both within and outside normal clinical levels with monopolar and bipolar stimulation.
MATERIALS AND METHODS
Six healthy guinea pigs were anaesthetised with ketamine (40 mg/kg) and xylazine (4 m a g ) and were maintained at surgical levels of anaesthesia during the experiment. The four most apical platinum (Pt) electrodes of a standard Nucleus electrode array were carefully inserted into the scala tympani. An extracochlear Pt electrode was placed in the musculature outside the cochlea.
Biphasic constant current pulses were generated from a modified, box-mounted version of the Nucleus CI24M receiver/stimulator. The Nucleus CI24M device was powered and controlled from a purpose built interface board connected in to an IBM PC. This system allowed an arbitrary sequence of stimulation pulses to be defined and repeatedly presented to the electrodes with parameters such as pulse width, current amplitude and stimulus rate all independently variable. Current pulses at total rates of 1,200 -14,500 pps were delivered to the four electrodes. The current amplitude was set at 0.2, 0.875 or 1.75 mA and pulse widths of 26,50, 100 or 200 */phase were used in monopolar and bipolar stimulation modes. Each stimulus condition in the monopolar mode was performed with and without a capacitor in series with the extracochlear electrode.
A parallel combination of a 47 pF capacitor and a 10 WZ resistor was placed in series with each intracochlear electrode. The voltage across each RC circuit was measured using battery operated digital voltmeters (10 M Q input impedance; Fluke 8060A) providing a resolution of 1 nanoampere (nA).
The care and use of animals involved in this study was approved by the Animal Experimentation Ethics Committee of the Royal Victorian Eye and Ear Hospital ('Cochlear Implants: Neural damage mechanisms in the auditory nerve' # 92-016A).
RESULTS:
In a preliminary study using high intensity bipolar stimulation the DC level measured in vivo was 3.2 and 2.8 times that of the values measured in human serum albumen and saline respectively. Because of the large discrepancy noted between the in vivo and in vitro values the decision was made to use an in vivo rather than an in vitro model for this study.
Both monopolar and bipolar stimulation showed DC levels increased as a function of stimulus rate, pulse width and stimulus intensity. In general, DC levels were higher in bipolar stimulation than in monopolar stimulation. Monopolar stimulation with a capacitively coupled extracochlear electrode showed even lower DC levels in the intracochlear electrodes.
For monopolar stimulation, using a capacitor in series with the extracochlear electrode, the DC levels were almost zero at pulse widths of 25 and 50 pdphase even at the highest rate (8500 -14,500 pps/4 channels). With pulse widths of up to 200 pdphase or stimulus intensities up to 1.75 mA, which are outside the normal clinical level, some DC levels (less than 30 nA) were observed. It should be noted that even in the case of a capacitively coupled extracochlear electrode it is still possible for small DC to be present in the intracochlear electrodes. This is because it is only necessary for the sum of DC in the intracochlear electrodes to be zero, not the individual electrode current. Stimulation without a coupling capacitor showed slightly higher DC level but still less than 100 nA for the same stimulus conditions. Using a stimulus intensity of 0.875 mA, the mean DC levels for bipolar stimulation (16 stimulating electrodes from 4 animals) were 80 nA for 26 pdphase; 105 nA for 50 plphase; and 138nA for 100 pdphase at the stimulus rates of 14500, 8500, and 4600 ppsI4 channels respectively, corresponding to a shorting period as low as 7 ps.
DISCUSSION:
There has been increasing interest in speech processing strategies using high pulse rate stimulation (>500-1000 pulses/s per channel) to provide fine temporal cues for cochlear implant patients. The present study has demonstrated that the Nucleus electrode shorting system can effectively minimize DC at stimulus rates of up to 14500 pps/4 channels with pulse widths of 26-50 pslphase for both monopolar and bipolar stimulation. Monopolar stimulation showed even greater reduction in DC level in the intracochlear electrode, especially with a capacitively coupled extracochlear electrode, with DC levels of less than 30 nA using stimulus intensities outside the normal clinical range. The results of this study showed DC increased as a function of stimulus rate, pulse width and stimulus intensity for both monopolar and bipolar stimulation. Our results were obtained from an animal model using a modified clinical device, indicating the data is clinically relevant. It has important practical implications for selection of safe stimulus parameters and stimulation configurations for cochlear implants. The mechanism(s) responsible for the significantly elevated DC observed in vivo compared with in vitro are currently under investigation.
